Condition: Patients With Cardiovascular Disease · Healthy Participants · Sponsor: University of Erlangen-Nürnberg Medical School
This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
This description comes directly from the study's public registry record.
Agnes Bosch, MD · +49 9131 8536245 · agnes.bosch@uk-erlangen.de
Dennis Kannenkeril, MD · +49 911 80099760 · CRC.M4@uk-erlangen.de
Always discuss trial participation with your own doctor first.
| University of Erlangen Nuremberg | Erlangen, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07359664